Systemtherapie des metastasierten Tumors des oberen HarntraktesSystemic treatment of metastatic tumors of the upper urinary tract

被引：0
|
作者：
C. Darr
B. A. Hadaschik
S. Tschirdewahn
机构：
[1] Universitätsmedizin Essen,Klinik und Poliklinik für Urologie, Kinderurologie und Uroonkologie
来源：
Der Urologe | 2019年 / 58卷 / 1期
关键词：
Urothelkarzinom; Chemotherapie; Immuntherapie; Harnblasenkarzinom; Gemcitabin; Urothelial carcinoma; Chemotherapy; Immunotherapy; Bladder cancer; Gemcitabin;
D O I：
10.1007/s00120-018-0835-8
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：30 / 33
页数：3
相关论文
共 50 条
  • [21] Organ-sparing treatment for upper urinary tract tumors in the single functioning kidney in the presence of anatomic anomaly
    Roshchin, D. A.
    Perepechin, D. V.
    Kachmazov, A. A.
    ONKOUROLOGIYA, 2014, 10 (04): : 83 - 86
  • [22] Molecular profile of urothelial carcinoma of the upper urinary tract: are pelvicalyceal and ureteral tumors different?
    Laura-Maria Krabbe
    Aditya Bagrodia
    Mary E. Westerman
    Bishoy A. Gayed
    Ahmed Q. Haddad
    Arthur I. Sagalowsky
    Shahrokh F. Shariat
    Payal Kapur
    Yair Lotan
    Vitaly Margulis
    World Journal of Urology, 2016, 34 : 105 - 112
  • [23] Molecular profile of urothelial carcinoma of the upper urinary tract: are pelvicalyceal and ureteral tumors different?
    Krabbe, Laura-Maria
    Bagrodia, Aditya
    Westerman, Mary E.
    Gayed, Bishoy A.
    Haddad, Ahmed Q.
    Sagalowsky, Arthur I.
    Shariat, Shahrokh F.
    Kapur, Payal
    Lotan, Yair
    Margulis, Vitaly
    WORLD JOURNAL OF UROLOGY, 2016, 34 (01) : 105 - 112
  • [24] Medikamentöse Therapie bei metastasierten neuroendokrinen Tumoren des gastroenteropankreatischen SystemsMedicinal therapy of metastasized neuroendocrine tumors of the gastroenteropancreatic system
    C.J. Auernhammer
    C. Spitzweg
    V. Heinemann
    B. Göke
    Der Internist, 2012, 53 (2): : 167 - 176
  • [25] Medikamentöse Therapie bei metastasierten neuroendokrinen Tumoren des gastroenteropankreatischen SystemsMedicinal therapy of metastasized neuroendocrine tumors of the gastroenteropancreatic system
    C.J. Auernhammer
    C. Spitzweg
    V. Heinemann
    B. Göke
    Wiener klinisches Magazin, 2013, 16 (3) : 16 - 23
  • [26] Medikamentöse Therapie des metastasierten oder rezidivierten mutationsnegativen NSCLCMedicinal treatment of metastatic or recurrent NSCLC without driver mutations
    Achim Rittmeyer
    Der Onkologe, 2018, 24 (12): : 1003 - 1008
  • [27] Medikamentöse Therapie des metastasierten oder rezidivierten mutationsnegativen NSCLCMedicinal treatment of metastatic or recurrent NSCLC without driver mutations
    Achim Rittmeyer
    Wiener klinisches Magazin, 2019, 22 (2) : 68 - 73
  • [28] Volumetric In Vivo Visualization of Upper Urinary Tract Tumors Using Optical Coherence Tomography: A Pilot Study
    Bus, Mieke T. J.
    Muller, Berrend G.
    de Bruin, Daniel M.
    Faber, Dirk J.
    Kamphuis, Guido M.
    van Leeuwen, Ton G.
    de Reijke, Theo M.
    de la Rosette, Jean J. M. C. H.
    JOURNAL OF UROLOGY, 2013, 190 (06) : 2236 - 2242
  • [29] Evaluation of Upper Urinary Tract Tumors With Portal Venous Phase MDCT: A Case-Control Study
    Kupershmidt, Max
    Margolis, Myles
    Jang, Hyun-Jung
    Massey, Christine
    Metser, Ur
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2011, 197 (02) : 424 - 428
  • [30] Epidemiology and risk factors of upper urinary tract tumors: Literature review for the yearly scientific report of the French National Association of Urology
    Ouzzane, A.
    Roupret, M.
    Leon, P.
    Yates, D. R.
    Colin, P.
    PROGRES EN UROLOGIE, 2014, 24 (15): : 966 - 976
12345